use of nicotinic acetylcholine alpha 7 receptor agonists for the treatment, improvement, prevention or delayed progression of fatigue

• 收藏
• 分享

专利权人:

NOVARTIS AG

发明人:

CRISTINA LOPEZ-LOPEZ,DOMINIK FEUERBACH,DONALD JOHNS,Judit Sovago,Kevin Hall MCAllister,MARKUS WEISS,Markus Fendt

申请号：

BR112015016992

公开号：

BR112015016992A2

申请日:

2014.01.13

申请国别(地区):

BR

年份:

2017

代理人:

摘要：

Summary The invention consists of the use of certain nicotinic alpha 7 acetylcholine receptor agonists for treating, ameliorating, preventing or delaying the progression of fatigue.resumo a invenção consiste no uso de certos agonistas do receptor alfa 7 nicotínico de acetilcolina para o tratamento, melhoria, prevenção ou demora no progresso da fadiga.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/